<DOC>
	<DOCNO>NCT00001991</DOCNO>
	<brief_summary>To facilitate provision atovaquone ( 566C80 ) patient mild moderate Pneumocystis carinii pneumonia ( PCP ) intolerant and/or unresponsive trimethoprim / sulfamethoxazole ( TMP / SMX ) ; monitor serious adverse event attributable 566C80 .</brief_summary>
	<brief_title>A Treatment IND 566C80 Therapy Pneumocystis Carinii Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Atovaquone</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>Inclusion Criteria Patients must follow : Clinical diagnosis acute mild moderate Pneumocystis carinii pneumonia . Doselimiting intolerance TMP / SMX inadequate response TMP / SMX . Willingness ability give inform consent . The clinical condition patient appropriate physiologic criterion use evaluate patient therapy 566C80 . Patients rapidly progress disease severity severe disease evidence sustain tachypnea ( e.g. , sustained respiratory rate &gt; 30 breaths/minute ) , rapid deterioration ( Aa ) DO2 chest radiograph may appropriate candidate oral therapy , include 566C80 . Therapy parenteral pentamidine undertaken case . Treatment IV trimetrexate primaquine / clindamycin consider patient unless patient know doselimiting intolerance agent . Patients severe PCP intolerant and/or unresponsive therapy TMP / SMX parenteral pentamidine may enroll 566C80 openlabel compassionate plea protocol . Exclusion Criteria Patients follow prior condition exclude : History serious doselimiting adverse experience previous 566C80 therapy , think attributable drug .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2003</verification_date>
	<keyword>Trimethoprim-Sulfamethoxazole Combination</keyword>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Antifungal Agents</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>atovaquone</keyword>
</DOC>